|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
2R42CA153845-02
|
$1,227,385
|
$1,227,385
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
International Case Control Study of Malignant Glioma
|
5R01CA139020-06
|
$1,177,060
|
$1,177,060
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Sox9/NFIA Transcriptional Network In Malignant Glioma
|
1K01CA190235-01A1
|
$140,400
|
$140,400
|
GLASGOW, STACEY
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
5K07CA157923-05
|
$148,746
|
$148,746
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-02
|
$579,834
|
$579,834
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
In Vivo Drug Testing of Pediatric CNS Tumors Using Patient Derived Orthotopic Xen
|
1U01CA199288-01
|
$604,258
|
$604,258
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQD-5) Patient derived orthotopic xenograft models for drug response prediction
|
5R01CA185402-02
|
$324,033
|
$324,033
|
LI, XIONAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$378,620
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$13,458
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$21,966
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
SapC-DOPS Nanovesicles for Treating Glioblastoma Multiforme
|
5R44CA136017-06
|
$948,501
|
$948,501
|
XU, KEVIN
|
BEXION PHARMACEUTICALS, INC.
|
|
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
|
1R44CA195749-01
|
$976,447
|
$976,447
|
CRAPO, JAMES
|
BIOMIMETIX JV, LLC
|
|
Dysregulation of mTORC2 in gliomas
|
5R01CA168700-04
|
$229,703
|
$229,703
|
GERA, JOSEPH
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$1,025
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$24,311
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$299,024
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
1R01CA195532-01
|
$396,329
|
$396,329
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Indirubins: novel anti-invasive and anti-angiogenic drugs for malignant gliomas
|
5R01CA166172-03
|
$367,707
|
$367,707
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MicroRNA128 Regulation of Polycomb Repressor Complexes1 and 2 in Glioblastoma
|
5R01CA176203-02
|
$346,881
|
$346,881
|
GODLEWSKI, JAKUB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Resting-state fMRI for Language Mapping in Brain Tumor Patients
|
1R21CA198740-01
|
$231,474
|
$231,474
|
GOLBY, ALEXANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Quantitative Image Informatics for Cancer Research (QIICR)
|
5U24CA180918-03
|
$757,535
|
$249,987
|
KIKINIS, RON
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MRI-guided focused ultrasound for drug delivery and ablation of brain tumors
|
5P01CA174645-03
|
$1,259,246
|
$843,695
|
MCDANNOLD, NATHAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Open source diffusion MRI technology for brain cancer research
|
1U01CA199459-01
|
$368,226
|
$368,226
|
O'DONNELL, LAUREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
5U24CA160034-05
|
$3,155,021
|
$788,755
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Nanosystems Biology Cancer Center
|
1U54CA199090-01
|
$2,324,988
|
$1,697,241
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
1R01CA187780-01A1
|
$362,569
|
$362,569
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
5R01CA179956-03
|
$616,995
|
$616,995
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Loss of Fractalkine Signaling Affects CNS Tumor Growth via Microglia Interactions
|
1F31CA196265-01
|
$35,879
|
$35,879
|
DORAND, RODNEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S1
|
$37,026
|
$7,035
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-25S2
|
$49,999
|
$9,500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-25
|
$4,878,887
|
$926,989
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Treatment of glioblastoma using chain-like nanoparticles
|
1U01CA198892-01
|
$576,094
|
$576,094
|
KARATHANASIS, EFSTATHIOS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-01S1
|
$171,796
|
$8,590
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-02
|
$1,360,245
|
$68,012
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
|
1R01CA187053-01A1
|
$362,569
|
$362,569
|
WELFORD, SCOTT
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$14,567
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$51,577
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$133,607
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$206,498
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$15,380
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$175,180
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$16,571
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$5,418,068
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
5K07CA178100-03
|
$130,652
|
$130,652
|
HOCKING, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Pediatric Phase 1/Pilot Consortium
|
5UM1CA097452-14
|
$3,118,345
|
$1,746,273
|
WEIGEL, BRENDA
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The role of ATRX and H3.3 mutations in pediatric glioblastoma
|
5F32CA189741-02
|
$54,194
|
$54,194
|
ANASTAS, JAMIE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Posterior cerebellar resection and pain processing in the pediatric brain
|
5R21CA185870-02
|
$230,876
|
$230,876
|
MOULTON, ERIC
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Genomic Analysis of Medulloblastomas
|
5R01CA109467-10
|
$695,928
|
$695,928
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL CORPORATION
|
Total relevant funding to Brain for this search: $202,158,714
|